Chronic transfusion practice for children with sickle cell anaemia and stroke

Banu Aygun, Marsha A. McMurray, William H. Schultz, Janet L. Kwiatkowski, Lee Hilliard, Ofelia A Alvarez, Matthew Heeney, Karen Kalinyak, Margaret T. Lee, Scott Miller, Ronald W. Helms, Russell E. Ware

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Chronic transfusions to maintain haemoglobin S (HbS) ≤30% are the mainstay of treatment for children with sickle cell anaemia (SCA) and previous stroke. This HbS target is often hard to maintain, however, and values achieved in current practice are unknown. In preparation for the Phase III Stroke With Transfusions Changing to Hydroxyurea (SWiTCH) trial, we collected data on 295 children with SCA and stroke who received transfusions at 23 institutions. The overall average pre-transfusion %HbS was 35 ± 11% (institutional range 22-51%). Receiving scheduled transfusions on time was the most predictive variable for maintaining HbS at the ≤30% goal.

Original languageEnglish
Pages (from-to)524-528
Number of pages5
JournalBritish Journal of Haematology
Volume145
Issue number4
DOIs
StatePublished - May 1 2009

Fingerprint

Sickle Hemoglobin
Sickle Cell Anemia
Stroke
Hydroxyurea

Keywords

  • %Hb S level
  • Sickle cell anaemia
  • Stroke
  • Transfusion

ASJC Scopus subject areas

  • Hematology

Cite this

Aygun, B., McMurray, M. A., Schultz, W. H., Kwiatkowski, J. L., Hilliard, L., Alvarez, O. A., ... Ware, R. E. (2009). Chronic transfusion practice for children with sickle cell anaemia and stroke. British Journal of Haematology, 145(4), 524-528. https://doi.org/10.1111/j.1365-2141.2009.07630.x

Chronic transfusion practice for children with sickle cell anaemia and stroke. / Aygun, Banu; McMurray, Marsha A.; Schultz, William H.; Kwiatkowski, Janet L.; Hilliard, Lee; Alvarez, Ofelia A; Heeney, Matthew; Kalinyak, Karen; Lee, Margaret T.; Miller, Scott; Helms, Ronald W.; Ware, Russell E.

In: British Journal of Haematology, Vol. 145, No. 4, 01.05.2009, p. 524-528.

Research output: Contribution to journalArticle

Aygun, B, McMurray, MA, Schultz, WH, Kwiatkowski, JL, Hilliard, L, Alvarez, OA, Heeney, M, Kalinyak, K, Lee, MT, Miller, S, Helms, RW & Ware, RE 2009, 'Chronic transfusion practice for children with sickle cell anaemia and stroke', British Journal of Haematology, vol. 145, no. 4, pp. 524-528. https://doi.org/10.1111/j.1365-2141.2009.07630.x
Aygun, Banu ; McMurray, Marsha A. ; Schultz, William H. ; Kwiatkowski, Janet L. ; Hilliard, Lee ; Alvarez, Ofelia A ; Heeney, Matthew ; Kalinyak, Karen ; Lee, Margaret T. ; Miller, Scott ; Helms, Ronald W. ; Ware, Russell E. / Chronic transfusion practice for children with sickle cell anaemia and stroke. In: British Journal of Haematology. 2009 ; Vol. 145, No. 4. pp. 524-528.
@article{7634463043c54cdd9c570bed9262ff23,
title = "Chronic transfusion practice for children with sickle cell anaemia and stroke",
abstract = "Chronic transfusions to maintain haemoglobin S (HbS) ≤30{\%} are the mainstay of treatment for children with sickle cell anaemia (SCA) and previous stroke. This HbS target is often hard to maintain, however, and values achieved in current practice are unknown. In preparation for the Phase III Stroke With Transfusions Changing to Hydroxyurea (SWiTCH) trial, we collected data on 295 children with SCA and stroke who received transfusions at 23 institutions. The overall average pre-transfusion {\%}HbS was 35 ± 11{\%} (institutional range 22-51{\%}). Receiving scheduled transfusions on time was the most predictive variable for maintaining HbS at the ≤30{\%} goal.",
keywords = "{\%}Hb S level, Sickle cell anaemia, Stroke, Transfusion",
author = "Banu Aygun and McMurray, {Marsha A.} and Schultz, {William H.} and Kwiatkowski, {Janet L.} and Lee Hilliard and Alvarez, {Ofelia A} and Matthew Heeney and Karen Kalinyak and Lee, {Margaret T.} and Scott Miller and Helms, {Ronald W.} and Ware, {Russell E.}",
year = "2009",
month = "5",
day = "1",
doi = "10.1111/j.1365-2141.2009.07630.x",
language = "English",
volume = "145",
pages = "524--528",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Chronic transfusion practice for children with sickle cell anaemia and stroke

AU - Aygun, Banu

AU - McMurray, Marsha A.

AU - Schultz, William H.

AU - Kwiatkowski, Janet L.

AU - Hilliard, Lee

AU - Alvarez, Ofelia A

AU - Heeney, Matthew

AU - Kalinyak, Karen

AU - Lee, Margaret T.

AU - Miller, Scott

AU - Helms, Ronald W.

AU - Ware, Russell E.

PY - 2009/5/1

Y1 - 2009/5/1

N2 - Chronic transfusions to maintain haemoglobin S (HbS) ≤30% are the mainstay of treatment for children with sickle cell anaemia (SCA) and previous stroke. This HbS target is often hard to maintain, however, and values achieved in current practice are unknown. In preparation for the Phase III Stroke With Transfusions Changing to Hydroxyurea (SWiTCH) trial, we collected data on 295 children with SCA and stroke who received transfusions at 23 institutions. The overall average pre-transfusion %HbS was 35 ± 11% (institutional range 22-51%). Receiving scheduled transfusions on time was the most predictive variable for maintaining HbS at the ≤30% goal.

AB - Chronic transfusions to maintain haemoglobin S (HbS) ≤30% are the mainstay of treatment for children with sickle cell anaemia (SCA) and previous stroke. This HbS target is often hard to maintain, however, and values achieved in current practice are unknown. In preparation for the Phase III Stroke With Transfusions Changing to Hydroxyurea (SWiTCH) trial, we collected data on 295 children with SCA and stroke who received transfusions at 23 institutions. The overall average pre-transfusion %HbS was 35 ± 11% (institutional range 22-51%). Receiving scheduled transfusions on time was the most predictive variable for maintaining HbS at the ≤30% goal.

KW - %Hb S level

KW - Sickle cell anaemia

KW - Stroke

KW - Transfusion

UR - http://www.scopus.com/inward/record.url?scp=65349084954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65349084954&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2009.07630.x

DO - 10.1111/j.1365-2141.2009.07630.x

M3 - Article

C2 - 19344396

AN - SCOPUS:65349084954

VL - 145

SP - 524

EP - 528

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 4

ER -